title: Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.
abstract: The effect of simvastatin in 27 patients with severe primary hypercholesterolaemia was assessed by a double-blind placebo controlled parallel group trial. Total serum cholesterol, LDL-cholesterol and apoprotein B (ApoB) were significantly reduced by simvastatin 40 mg daily. Reductions in triglyceride and VLDL-cholesterol and an increase in HDL-cholesterol levels were only significant when calculated as a percentage of baseline, because of wide inter-individual variability. No changes in apoprotein A1, lipoprotein (a), fibrinogen, viscosity or blood pressure were observed. Leucocyte HMG-CoA reductase activity was unchanged after 4 weeks of active treatment but increased by 87% after 3 months (n = 21, P less than 0.05). No severe adverse effects or changes in CK or AST levels were noted. We conclude that simvastatin is effective in the treatment of severe and resistant hypercholesterolaemia, and well tolerated in the short term.
authors.affiliation: Royal Victoria Hospital, Belfast, Northern Ireland.
authors.forename: I F
authors.initials: IF
authors.lastname: McDowell
authors.forename: M
authors.initials: M
authors.lastname: Smye
authors.forename: T
authors.initials: T
authors.lastname: Trinick
authors.forename: J A
authors.initials: JA
authors.lastname: Shortt
authors.forename: M P
authors.initials: MP
authors.lastname: Archibald
authors.forename: E R
authors.initials: ER
authors.lastname: Trimble
authors.forename: D P
authors.initials: DP
authors.lastname: Nicholls
mesh_terms: D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001055:Apolipoproteins B / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D006937:Hypercholesterolemia / Q000188:drug therapy*; D007962:Leukocytes / Q000201:enzymology; D008055:Lipids / Q000097:blood; D008099:Liver / Q000201:enzymology; D008148:Lovastatin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019821:Simvastatin; D000637:Transaminases / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D001055:Apolipoproteins B; D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin; D006903:Hydroxymethylglutaryl CoA Reductases; D000637:Transaminases